Showing results (21-30 of 252) with videos related to
Sort By:
Pageof 26
Liver International : Official Journal of the International Association for the Study of the Liver|July 21, 2023
Risk of infections in non-alcoholic fatty liver disease: A nationwide population-based cohort studyYing Shang, Linnea Widman, Fahim Ebrahimi, et al.Clinical and Molecular Hepatology|July 15, 2026
Oral anticoagulants and hepatic decompensation in patients with cirrhosis and atrial fibrillation: observational studyAxel Wester, Emilie Toresson Grip, Rupesh Rajani, et al.Alimentary Pharmacology & Therapeutics|October 2, 2024
Timely Follow-Up After a First Diagnosis of Cirrhosis is Associated With Reduced Mortality but No Impact on Rehospitalisations: A Population-Based Cohort of 8852 PatientsMax S Schechter, Linnea Widman, Axel Wester, et al.Gastro Hep Advances|September 16, 2024
Lower Incidence of HCC and Other Major Adverse Liver Outcomes in People Living With HIV and Chronic Liver DiseaseMaurice Michel, Hannes Hagström, Linnea Widman, et al.European Journal of Internal Medicine|February 14, 2025
Risk of hepatic decompensation or HCC is similar in patients with ALD- and MASLD-cirrhosis: A population-based cohort studyJoost Boeckmans, Linnea Widman, Ying Shang, et al.Liver International : Official Journal of the International Association for the Study of the Liver|September 2, 2024
Socioeconomic factors associated with the presence of and outcomes in metabolic dysfunction-associated steatotic liver diseasePatrik Nasr, Ying Shang, Axel Wester, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 18, 2024
Misclassified Alcohol-related Liver Disease is Common in Presumed Metabolic Dysfunction-associated Steatotic Liver Disease and Highly Increases Risk for Future CirrhosisPatrik Nasr, Axel Wester, Mattias Ekstedt, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 28, 2023
Risk of Severe Infection in Patients With Biopsy-proven Nonalcoholic Fatty Liver Disease - A Population-based Cohort StudyFahim Ebrahimi, Tracey G Simon, Hannes Hagström, et al.Journal of Hepatology|April 14, 2025
Phosphatidylethanol levels distinguish steatotic liver disease subgroups and are associated with risk of major liver outcomesJuan Vaz, Patrik Nasr, Anders Helander, et al.Best Practice & Research. Clinical Gastroenterology|December 3, 2017
Alcohol, smoking and the liver disease patientHannes HagströmPageof 26